{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:50:12Z","timestamp":1793332212687,"version":"4.5.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"6","funder":[{"DOI":"10.13039\/100000002","name":"National Cancer Institute National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Cancer Institute National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1093\/jnci\/djv086","type":"journal-article","created":{"date-parts":[[2015,4,29]],"date-time":"2015-04-29T21:02:36Z","timestamp":1430341356000},"source":"Crossref","is-referenced-by-count":687,"title":["US Assessment of HPV Types in Cancers: Implications for Current and 9-Valent HPV Vaccines"],"prefix":"10.1093","volume":"107","author":[{"given":"Mona","family":"Saraiya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor D.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles F.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda Y.","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Steinau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Hopenhayn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy","family":"Cozen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward S.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sibug","family":"Saber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Altekruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc T.","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,4,29]]},"reference":[{"key":"key\n\t\t\t\t20170521013520_CIT0001","first-page":"342","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume-title":"Nat Rev Cancer","year":"2002"},{"issue":"Suppl 5","key":"key\n\t\t\t\t20170521013520_CIT0002","first-page":"F12","article-title":"Global burden of human papillomavirus and related diseases","volume":"30","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170521013520_CIT0003","volume-title":"Monographs on the evaluation of carcinogenic risks to humans: biologic agents. Human papillomaviruses","author":"International Agency for Research on Cancer IARC","year":"2012"},{"key":"key\n\t\t\t\t20170521013520_CIT0004","first-page":"321","article-title":"A review of human carcinogens-Part B: biological agents","volume-title":"The Lancet Oncol","year":"2009"},{"issue":"Suppl 5","key":"key\n\t\t\t\t20170521013520_CIT0005","first-page":"F55","article-title":"The biology and life-cycle of human papillomaviruses","volume":"30","year":"2012","journal-title":"Vaccine"},{"issue":"32","key":"key\n\t\t\t\t20170521013520_CIT0006","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States","volume":"29","year":"2011","journal-title":"J Clin Oncol"},{"issue":"10 Suppl","key":"key\n\t\t\t\t20170521013520_CIT0007","first-page":"3036","article-title":"HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women","volume":"113","year":"2008","journal-title":"Cancer"},{"issue":"3","key":"key\n\t\t\t\t20170521013520_CIT0008","article-title":"Early impact of human papillomavirus vaccination on cervical neoplasia--nationwide follow-up of young Danish women","volume":"106","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20170521013520_CIT0009","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/1741-7015-11-227","article-title":"Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study","volume":"11","year":"2013","journal-title":"BMC Med"},{"issue":"17","key":"key\n\t\t\t\t20170521013520_CIT0010","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMoa1010971","article-title":"HPV vaccine against anal HPV infection and anal intraepithelial neoplasia","volume":"365","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"key\n\t\t\t\t20170521013520_CIT0011","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170521013520_CIT0012","doi-asserted-by":"crossref","first-page":"c3493","DOI":"10.1136\/bmj.c3493","article-title":"Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial","volume":"341","author":"FUTURE I\/II Study Group","year":"2010","journal-title":"BMJ"},{"issue":"9","key":"key\n\t\t\t\t20170521013520_CIT0013","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S1470-2045(11)70213-3","article-title":"Efficacy of a bivalent HPV 16\/18 vaccine against anal HPV 16\/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial","volume":"12","year":"2011","journal-title":"Lancet Oncol"},{"issue":"7","key":"key\n\t\t\t\t20170521013520_CIT0014","doi-asserted-by":"crossref","first-page":"e68329","DOI":"10.1371\/journal.pone.0068329","article-title":"Reduced prevalence of oral humanpapillomavirus (HPV) 4 Years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170521013520_CIT0015","author":"Food and Drug Administration"},{"issue":"11","key":"key\n\t\t\t\t20170521013520_CIT0016","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1586\/14760584.2014.963561","article-title":"The next generation of HPV vaccines: nonavalent vaccine V503 on the horizon","volume":"13","year":"2014","journal-title":"Expert Rev Vaccines"},{"issue":"1","key":"key\n\t\t\t\t20170521013520_CIT0017","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-9378-7-38","article-title":"Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease","volume":"7","year":"2012","journal-title":"Infect Agent Cancer"},{"issue":"29","key":"key\n\t\t\t\t20170521013520_CIT0018","first-page":"591","volume":"62","author":"CDC. Human papillomavirus vaccination coverage among adolescent girls, 2007\u20132012, and postlicensure vaccine safety monitoring, 2006\u20132013 - United States","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"key\n\t\t\t\t20170521013520_CIT0019","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","year":"2010","journal-title":"Lancet Oncol"},{"issue":"4","key":"key\n\t\t\t\t20170521013520_CIT0020","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/LGT.0b013e3182472947","article-title":"Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction","volume":"16","year":"2012","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"key\n\t\t\t\t20170521013520_CIT0021","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/LGT.0b013e31827ed372","article-title":"Human papillomavirus prevalence in invasive anal cancers in the United States before vaccine introduction","volume":"17","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"key\n\t\t\t\t20170521013520_CIT0022","first-page":"9","article-title":"Human papillomavirus genotype prevalence in invasive penile cancers from a registry-based United States population","volume":"4","year":"2014","journal-title":"Front Oncol"},{"issue":"2","key":"key\n\t\t\t\t20170521013520_CIT0023","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/LGT.0b013e3182a577c7","article-title":"Prevalence of human papillomavirus types in invasive cervical cancers from 7 US cancer registries before vaccine introduction","volume":"18","year":"2014","journal-title":"J Low Genit Tract Dis"},{"issue":"4","key":"key\n\t\t\t\t20170521013520_CIT0024","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/AOG.0000000000000171","article-title":"Human papillomavirus genotype prevalence in invasive vaginal cancer from a registry-based population","volume":"123","year":"2014","journal-title":"Obstet Gynecol"},{"issue":"1","key":"key\n\t\t\t\t20170521013520_CIT0025","first-page":"61","article-title":"A real-time PCR assay for HPV52 detection and viral load quantification","volume":"58","year":"2012","journal-title":"Clin Lab"},{"issue":"7","key":"key\n\t\t\t\t20170521013520_CIT0026","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1158\/1055-9965.EPI-07-2922","article-title":"A systematic review of the prevalence and attribution of human papillomavirus types among cervical, vaginal, and vulvar precancers and cancers in the United States","volume":"17","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"9","key":"key\n\t\t\t\t20170521013520_CIT0027","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1002\/ijc.24528","article-title":"Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants","volume":"125","year":"2009","journal-title":"Int J Cancer"},{"issue":"3","key":"key\n\t\t\t\t20170521013520_CIT0028","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/jnci\/djs491","article-title":"Annual Report to the Nation on the Status of Cancer, 1975\u20132009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels","volume":"105","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20170521013520_CIT0029","first-page":"258","volume":"61","author":"CDC. Human papillomavirus-associated cancers - United States, 2004\u20132008","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"key\n\t\t\t\t20170521013520_CIT0030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ijc.28963","article-title":"Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide","volume":"136","year":"2015","journal-title":"Int J Cancer"},{"issue":"4","key":"key\n\t\t\t\t20170521013520_CIT0031","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ijc.25396","article-title":"Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication","volume":"128","year":"2011","journal-title":"Int J Cancer"},{"issue":"7","key":"key\n\t\t\t\t20170521013520_CIT0032","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn510","article-title":"Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States","volume":"101","year":"2009","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"key\n\t\t\t\t20170521013520_CIT0033","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1002\/ijc.27485","article-title":"Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer","volume":"131","year":"2012","journal-title":"Int J Cancer"},{"issue":"1","key":"key\n\t\t\t\t20170521013520_CIT0034","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","year":"1999","journal-title":"J Pathol"},{"issue":"1","key":"key\n\t\t\t\t20170521013520_CIT0035","first-page":"45","article-title":"Primary cervical cancer truly negative for high-risk human papillomavirus is a rare but distinct entity that can affect virgins and young adolescents","volume":"30","year":"2009","journal-title":"Eur J Gynaecol Oncol"},{"issue":"12","key":"key\n\t\t\t\t20170521013520_CIT0036","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/infdis\/jis627","article-title":"Human papillomavirus genotypes in high-grade cervical lesions in the United States","volume":"206","year":"2012","journal-title":"J Infect Dis"},{"issue":"Suppl 5","key":"key\n\t\t\t\t20170521013520_CIT0037","first-page":"F24","article-title":"Updating the natural history of human papillomavirus and anogenital cancers","volume":"30","year":"2012","journal-title":"Vaccine"},{"issue":"7","key":"key\n\t\t\t\t20170521013520_CIT0038","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1158\/1055-9965.EPI-13-0053","article-title":"Age-specific occurrence of HPV16- and HPV18-related cervical cancer","volume":"22","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"key\n\t\t\t\t20170521013520_CIT0039","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s10552-008-9276-9","article-title":"Systematic review of human papillomavirus prevalence in invasive penile cancer","volume":"20","year":"2009","journal-title":"Cancer Causes Control"},{"issue":"Suppl 5","key":"key\n\t\t\t\t20170521013520_CIT0040","first-page":"F34","article-title":"Human papillomavirus and diseases of the upper airway: head and neck cancer and respiratory papillomatosis","volume":"30","year":"2012","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t20170521013520_CIT0041","article-title":"Estimation of the HPV etiological fraction in over 4,000 head and neck cancers worldwide","year":"2014"},{"issue":"5","key":"key\n\t\t\t\t20170521013520_CIT0042","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.oraloncology.2013.11.004","article-title":"Role of human papillomavirus in non-oropharyngeal head and neck cancers","volume":"50","year":"2014","journal-title":"Oral Oncol"},{"issue":"7","key":"key\n\t\t\t\t20170521013520_CIT0043","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.2012.101","article-title":"Prevalence of oral HPV infection in the United States, 2009\u20132010","volume":"307","year":"2012","journal-title":"JAMA"},{"issue":"1","key":"key\n\t\t\t\t20170521013520_CIT0044","doi-asserted-by":"crossref","first-page":"e86023","DOI":"10.1371\/journal.pone.0086023","article-title":"Differences in oral sexual behaviors by gender, age, and race explain observed differences in prevalence of oral human papillomavirus infection","volume":"9","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"key\n\t\t\t\t20170521013520_CIT0045","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1158\/1940-6207.CAPR-09-0149","article-title":"Racial survival disparity in head and neck cancer results from low prevalence of human papillomavirus infection in black oropharyngeal cancer patients","volume":"2","year":"2009","journal-title":"Cancer Prev Res (Phila)"},{"issue":"10 Suppl","key":"key\n\t\t\t\t20170521013520_CIT0046","first-page":"3047","article-title":"Cancer registries and monitoring the impact of prophylactic human papillomavirus vaccines: the potential role","volume":"113","year":"2008","journal-title":"Cancer"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/107\/6\/djv086\/17314839\/djv086.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T09:47:36Z","timestamp":1526636856000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/djv086"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,29]]},"references-count":46,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,4,29]]},"published-print":{"date-parts":[[2015,6]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/djv086","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4,29]]}}}